Ledger.Open graph →
SEC Form D · filed August 12, 2019

Artax Biopharma, Inc

Offering
$3.5M
Sold
$750K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Ihor Lys · LOS ANGELES, CADirectorEdwin Kania · LOS ANGELES, CADirectorDrew Anwyll · Toronto, Ontario, CanadaDirectorKen Deregt · New York, NYDirectorArne Brock-Utne · Lafayette, CADirectorDerek T. Yoon · Gaithersburg, MDDirectorRami Elghandour · Gaithersburg, MDDirectorDavid T. Lubner · Gaithersburg, MDDirectorDamia Tormo, Ph.D., Mbm · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗